{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:40:35Z","timestamp":1792172435049,"version":"4.4.0"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Haematological malignancies comprise a diverse set of lymphoid and myeloid neoplasms which can arise during any stage of haematopoiesis in the bone marrow. Accumulating evidence suggests that chronic inflammation generated by inflammatory cytokines secreted by tumour and the tumour-associated cells within the bone marrow microenvironment initiates signalling pathways in malignant cells, resulting in activation of master transcription factors including Smads, STAT3, and NF-\u03baB which confer cancer stem cell phenotypes and drive disease progression. Deciphering the molecular mechanisms for how immune cells interact with malignant cells to induce such epigenetic modifications, specifically DNA methylation, histone modification, expression of miRNAs and lnRNAs to perturbate haematopoiesis could provide new avenues for developing novel targeted therapies for haematological malignancies. Here, the complex positive and negative feedback loops involved in inflammatory cytokine-induced cancer stem cell generation and drug resistance are reviewed to highlight the clinical importance of immune-epigenetic crosstalk in haematological malignancies.<\/jats:p>","DOI":"10.3389\/fcell.2023.1233383","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:23:00Z","timestamp":1695471780000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Immune-epigenetic crosstalk in haematological malignancies"],"prefix":"10.3389","volume":"11","author":[{"given":"Hera","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohichi","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature15250","article-title":"Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal","volume":"526","author":"Acar","year":"2015","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: A double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-019-1011-5","article-title":"Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation","volume":"18","author":"Ai","year":"2019","journal-title":"Mol. Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00262-011-1054-y","article-title":"Th17 and Th17-stimulated CD8\u207a T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity","volume":"60","author":"Ankathatti Munegowda","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/blood-2016-02-699520","article-title":"Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma","volume":"128","author":"Assouline","year":"2016","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nature25193","article-title":"A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies","volume":"553","author":"Bahr","year":"2018","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/385729a0","article-title":"A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells","volume":"385","author":"Black","year":"1997","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1038\/s41375022016979","article-title":"A primary hierarchically organized patient derived model enables in depth interrogation of stemness driven by the coding and noncoding genome","volume":"36","author":"Boutzen","year":"2022","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/nm.3707","article-title":"Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion","volume":"20","author":"Bruns","year":"2014","journal-title":"Nat. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.stem.2010.02.001","article-title":"Endothelial cells are essential for the self-renewal and repopulation of notch-dependent hematopoietic stem cells","volume":"6","author":"Butler","year":"2010","journal-title":"Cell. Stem Cell."},{"key":"B13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.stem.2018.10.013","article-title":"Inhibition of inflammatory signaling in Tet2 mutant preleukemic cells mitigates stress-induced abnormalities and clonal hematopoiesis","volume":"23","author":"Cai","year":"2018","journal-title":"Cell. Stem Cell."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e20201541","DOI":"10.1084\/jem.20201541","article-title":"Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection","volume":"218","author":"Caiado","year":"2021","journal-title":"J. Exp. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.stem.2010.02.002","article-title":"Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1","volume":"6","author":"Challen","year":"2010","journal-title":"Cell. Stem Cell."},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng.1009","article-title":"Dnmt3a is essential for hematopoietic stem cell differentiation","volume":"44","author":"Challen","year":"2011","journal-title":"Nat. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3389\/fonc.2019.01380","article-title":"Therapeutic targeting of the macrophage immune checkpoint CD47 in myeloid malignancies","volume":"9","author":"Chao","year":"2020","journal-title":"Front. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1056\/nejmoa1808777","article-title":"Immune escape of relapsed AML cells after allogeneic transplantation","volume":"379","author":"Christopher","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell."},{"key":"B22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/leu.2012.312","article-title":"Azacitidine fails to eradicate leukemic stem\/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia","volume":"27","author":"Craddock","year":"2013","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/imm.12136","article-title":"Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma","volume":"140","author":"Cycon","year":"2013","journal-title":"Immunology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature08448","article-title":"JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin","volume":"461","author":"Dawson","year":"2009","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches","volume":"495","author":"Ding","year":"2013","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature10783","article-title":"Endothelial and perivascular cells maintain haematopoietic stem cells","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2015-12-688705","article-title":"Comprehensive mutational profiling of core binding factor acute myeloid leukemia","volume":"127","author":"Duployez","year":"2016","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1158\/2326-6066.cir-14-0161","article-title":"The immunological synapse","volume":"2","author":"Dustin","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7036","DOI":"10.1074\/jbc.m708690200","article-title":"NF-kappaB suppression by the deubiquitinating enzyme cezanne: A novel negative feedback loop in pro-inflammatory signaling","volume":"283","author":"Enesa","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/301089a0","article-title":"Hypomethylation distinguishes genes of some human cancers from their normal counterparts","volume":"301","author":"Feinberg","year":"1983","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1182\/blood-2018-99-120170","article-title":"Combination treatment with 5F9 and azacitidine enhances phagocytic elimination of acute myeloid leukemia","volume":"132","author":"Feng","year":"2018","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1600-065x.2006.00442.x","article-title":"Immune resistance orchestrated by the tumor microenvironment","volume":"213","author":"Gajewski","year":"2006","journal-title":"Immunol. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s12253-018-00574-0","article-title":"Real life data on efficacy and safety of azacitidine therapy for myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia","volume":"25","author":"Helbig","year":"2019","journal-title":"Pathology Oncol. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/nm.3665","article-title":"A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia","volume":"20","author":"Herranz","year":"2014","journal-title":"Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5278","DOI":"10.1038\/sj.onc.1208657","article-title":"The Runx1 transcription factor controls CSF-1-dependent and -independent growth and survival of macrophages","volume":"24","author":"Himes","year":"2005","journal-title":"Oncogene"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1158\/0008-5472.can-04-3589","article-title":"Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation","volume":"65","author":"Hodge","year":"2005","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature17624","article-title":"Distinct bone marrow blood vessels differentially regulate haematopoiesis","volume":"532","author":"Itkin","year":"2016","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2018.03.025","article-title":"Loss of Dnmt3a immortalizes hematopoietic stem cells in vivo","volume":"23","author":"Jeong","year":"2018","journal-title":"Cell. Rep."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/ncb2108","article-title":"Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells","volume":"12","author":"Kobayashi","year":"2010","journal-title":"Nat. Cell. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1126\/science.aac7049","article-title":"RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself","volume":"349","author":"Liddicoat","year":"2015","journal-title":"Science"},{"key":"B47","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell."},{"key":"B48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0092-8674(00)00121-5","article-title":"TGFbeta signaling in growth control, cancer, and heritable disorders","volume":"103","author":"Massagu\u00e9","year":"2000","journal-title":"Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1158\/1078-0432.ccr-07-2223","article-title":"The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance","volume":"14","author":"Meads","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nm.3647","article-title":"Hematopoietic stem cell niche maintenance during homeostasis and regeneration","volume":"20","author":"Mendelson","year":"2014","journal-title":"Nat. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/nejmra032906","article-title":"New drugs for rheumatoid arthritis","volume":"350","author":"Olsen","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell."},{"key":"B54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"10592","DOI":"10.1073\/pnas.1405546111","article-title":"Tif1\u03b3 regulates the TGF-\u03b21 receptor and promotes physiological aging of hematopoietic stem cells","volume":"111","author":"Qu\u00e9r\u00e9","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B56","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","article-title":"T-cell acute lymphoblastic leukemia","volume":"2016","author":"Raetz","year":"2016","journal-title":"Hematology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.4065\/80.10.1371","article-title":"Multiple myeloma: diagnosis and treatment","volume":"80","author":"Rajkumar","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1080\/10428190410001723322","article-title":"Remicade as TNF suppressor in patients with myelodysplastic syndromes","volume":"45","author":"Raza","year":"2004","journal-title":"Leukemia Lymphoma"},{"key":"B60","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2326-6066.cir-16-0201","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.4049\/jimmunol.150.12.5445","article-title":"CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene","volume":"150","author":"Rouvier","year":"1993","journal-title":"J. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1182\/blood-2019-126271","article-title":"The first-in-class anti-CD47 antibody magrolimab (5F9) in combination with azacitidine is effective in MDS and AML patients: ongoing phase 1b results","volume":"134","author":"Sallman","year":"2019","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2020.09.197","article-title":"Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis","volume":"91","author":"SanMiguel","year":"2020","journal-title":"Exp. Hematol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/jpet.301.2.418","article-title":"Binding and functional comparisons of two types of tumor necrosis factor antagonists","volume":"301","author":"Scallon","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","article-title":"Normal and leukemic stem cell niches: insights and therapeutic opportunities","volume":"16","author":"Schepers","year":"2015","journal-title":"Cell. Stem Cell."},{"key":"B66","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1046\/j.1365-2141.2002.03279.x","article-title":"Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes","volume":"116","author":"Stasi","year":"2002","journal-title":"Br. J. Haematol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology","volume":"15","author":"Steeve","year":"2004","journal-title":"Cytokine and Growth Factor Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1182\/blood-2011-07-367052","article-title":"An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification","volume":"119","author":"Stephens","year":"2012","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00262-016-1900-z","article-title":"Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma","volume":"65","author":"Tiper","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jnci\/djm135","article-title":"Drug resistance and the solid tumor microenvironment","volume":"99","author":"Tredan","year":"2007","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"B71","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1586\/14737140.2.3.277","article-title":"TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies","volume":"2","author":"Tsimberidou","year":"2002","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B72","first-page":"256","article-title":"BCL-X expression in multiple myeloma: possible indicator of chemoresistance","volume":"58","author":"Tu","year":"1998","journal-title":"Cancer Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.1002\/jcb.27882","article-title":"Loss of miR\u2010146b\u20105p promotes T cell acute lymphoblastic leukemia migration and invasion via the IL\u201017A pathway","volume":"120","author":"Tu","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2012","journal-title":"Oncogene"},{"key":"B75","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/bjh.12266","article-title":"A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma","volume":"161","author":"Voorhees","year":"2013","journal-title":"Br. J. Haematol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.trecan.2017.04.004","article-title":"Epigenetics and cancer stem cells: unleashing, hijacking, and restricting cellular plasticity","volume":"3","author":"Wainwright","year":"2017","journal-title":"Trends Cancer"},{"key":"B77","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/jci69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Investigation"},{"key":"B78","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1200\/jco.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ccell.2020.04.015","article-title":"Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia","volume":"37","author":"Witkowski","year":"2020","journal-title":"Cancer Cell."},{"key":"B80","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa031197","article-title":"Loss of Smad3 in acute T-cell lymphoblastic leukemia","volume":"351","author":"Wolfraim","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.stem.2019.05.019","article-title":"TNF-\u0391 coordinates hematopoietic stem cell survival and myeloid regeneration","volume":"25","author":"Yamashita","year":"2019","journal-title":"Cell. Stem Cell."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2011.09.053","article-title":"Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche","volume":"147","author":"Yamazaki","year":"2011","journal-title":"Cell."},{"key":"B83","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1158\/1078-0432.ccr-15-2584","article-title":"HDAC inhibitors enhance T-cell chemokine expression and augment response to PD-1 immunotherapy in lung adenocarcinoma","volume":"22","author":"Zheng","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.stem.2016.05.004","article-title":"ADAR1 activation drives leukemia stem cell self-renewal by impairing let-7 biogenesis","volume":"19","author":"Zipeto","year":"2016","journal-title":"Cell. Stem Cell."},{"key":"B86","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nat. Rev. Immunol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1233383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T12:23:03Z","timestamp":1695471783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2023.1233383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":86,"alternative-id":["10.3389\/fcell.2023.1233383"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2023.1233383","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"article-number":"1233383"}}